These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3981418)

  • 1. Pharmacokinetics of morphine and its surrogates V: Naltrexone and naltrexone conjugate pharmacokinetics in the dog as a function of dose.
    Garrett ER; el-Koussi A el-D
    J Pharm Sci; 1985 Jan; 74(1):50-6. PubMed ID: 3981418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of morphine and its surrogates. VIII: Naloxone and naloxone conjugate pharmacokinetics in dogs as a function of dose and as affected by simultaneously administered morphine.
    Garrett ER; Shyu WC; Ulubelen A
    J Pharm Sci; 1986 Dec; 75(12):1127-36. PubMed ID: 3559921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of morphine and its surrogates. VII: High-performance liquid chromatographic analyses and pharmacokinetics of methadone and its derived metabolites in dogs.
    Garrett ER; Derendorf H; Mattha AG
    J Pharm Sci; 1985 Nov; 74(11):1203-14. PubMed ID: 4087182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol.
    Malspeis L; Bathala MS; Ludden TM; Bhat HB; Frank SG; Sokoloski TD; Morrison BE; Reuning RH
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):43-65. PubMed ID: 810832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of morphine and its surrogates. III: Morphine and morphine 3-monoglucuronide pharmacokinetics in the dog as a function of dose.
    Garrett ER; Jackson AJ
    J Pharm Sci; 1979 Jun; 68(6):753-71. PubMed ID: 458581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of morphine and its surrogates. XI: Effect of simultaneously administered naltrexone and morphine on the pharmacokinetics and pharmacodynamics of each in the dog.
    Langguth P; Khan PJ; Garrett ER
    Biopharm Drug Dispos; 1990 Jul; 11(5):419-44. PubMed ID: 2207296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of morphine and its surrogates. X: Analyses and pharmacokinetics of buprenorphine in dogs.
    Garrett ER; Chandran VR
    Biopharm Drug Dispos; 1990; 11(4):311-50. PubMed ID: 2340348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stimulatory effect of morphine on reduction of naltrexone to 6 alpha-naltrexol in the guinea pig.
    Roerig SC; Fujimoto JM; Wang RI
    Drug Metab Dispos; 1980; 8(5):295-9. PubMed ID: 6107224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.
    Meyer MC; Straughn AB; Lo MW; Schary WL; Whitney CC
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):15-9. PubMed ID: 6469932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gas-liquid chromatographic method for the determination of naltrexone and beta-naltrexol in human urine.
    Verebely K; Mulé SJ; Jukofsky D
    J Chromatogr; 1975 Aug; 111(1):141-8. PubMed ID: 239958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrochemical chromatographic determinations of morphine antagonists in biological fluids, with applications.
    Derendorf H; El-Din A; El-Koussi A; Garrett ER
    J Pharm Sci; 1984 May; 73(5):621-4. PubMed ID: 6737235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone disposition in man after subcutaneous administration.
    Wall ME; Perez-Reyes M; Brine DR; Cook CE
    Drug Metab Dispos; 1984; 12(6):677-82. PubMed ID: 6150815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit.
    Taylor SM; Rodgers RM; Lynn RK; Gerber N
    J Pharmacol Exp Ther; 1980 May; 213(2):289-99. PubMed ID: 7365688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of naloxone and naltrexone in the dog.
    Pace NL; Parrish RG; Lieberman MM; Wong KC; Blatnick RA
    J Pharmacol Exp Ther; 1979 Feb; 208(2):254-6. PubMed ID: 762657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and choleretic effect of naltrexone in the isolated perfused rat liver.
    Rodgers RM; Taylor SM; Dickinson RG; Ilias AM; Lynn RK; Gerber N
    Drug Metab Dispos; 1980; 8(6):390-6. PubMed ID: 6109606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of naltrexone hydrochloride and naltrexone glucuronide in the dog].
    Li H; Zhao SF; Wang N; Ge ZH
    Yao Xue Xue Bao; 1996; 31(4):254-7. PubMed ID: 9208648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone: disposition, metabolism, and effects after acute and chronic dosing.
    Verebey K; Volavka J; Mulé SJ; Resnick RB
    Clin Pharmacol Ther; 1976 Sep; 20(3):315-28. PubMed ID: 954353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing of drug delivery systems for use in the treatment of narcotic addiction.
    Reuning RH; Malspeis L; Frank S; Notari RE
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):43-5. PubMed ID: 827709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of a naltrexone sustained-release preparation.
    Chiang CN; Hollister LE; Kishimoto A; Barnett G
    Clin Pharmacol Ther; 1984 Nov; 36(5):704-8. PubMed ID: 6488691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and inhibition of the formation of 6beta-naltrexol from naltrexone in human liver cytosol.
    Porter SJ; Somogyi AA; White JM
    Br J Clin Pharmacol; 2000 Nov; 50(5):465-71. PubMed ID: 11069441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.